Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cady

Showing results (61-70 of 85) with videos related to

Pageof 9
Sort By:
The Journal of Headache and Pain|February 9, 2017
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraineRoger K Cady, Sagar Munjal, Ryan J Cady, et al.
Drug Intelligence & Clinical Pharmacy|September 1, 1983
Ceforanide vs. cephalothin concentrations in total joint arthroplastyW J Cady, B G Wulf, M T O'Neil, et al.
European Journal of Clinical Pharmacology|January 1, 1981
The effects of erythromycin on the absorption and disposition of kinetics of theophyllineT A Branigan, R A Robbins, W J Cady, et al.
Bulletin Du Cancer|January 1, 1991
[Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer]C Louvet, A de Gramont, B Demuynck, et al.
JAMA|March 16, 1990
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapyJ F Burris, M R Weir, S Oparil, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 25, 2022
Development of the functional assessment of migraine scale using a patient guided approachErin M Buchanan, Heather R Manley, James S Sly, et al.
Journal of Human Hypertension|April 1, 1992
A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertensionM R Weir, M A Weber, H A Punzi, et al.
European Journal of Integrative Medicine|September 22, 2015
The Role of Salivary Neuropeptides in Pediatrics: Potential Biomarkers for Integrated TherapiesLynn A Gershan, Paul L Durham, Jaci Skidmore, et al.
American Heart Journal|February 1, 1980
Mexiletine in the treatment of refractory ventricular arrhythmias: a report of five casesW J Cady, C S Wilson, W A Chambers, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Acute effects of increasing doses of urapidil in patients with hypertensionV L Culbertson, P J Bryant, W J Cady, et al.
Pageof 9

Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
The Journal of Headache and Pain|February 9, 2017
Randomized, double-blind, crossover study comparing DFN-11 injection (3 mg subcutaneous sumatriptan) with 6 mg subcutaneous sumatriptan for the treatment of rapidly-escalating attacks of episodic migraineRoger K Cady, Sagar Munjal, Ryan J Cady, et al.
Drug Intelligence & Clinical Pharmacy|September 1, 1983
Ceforanide vs. cephalothin concentrations in total joint arthroplastyW J Cady, B G Wulf, M T O'Neil, et al.
European Journal of Clinical Pharmacology|January 1, 1981
The effects of erythromycin on the absorption and disposition of kinetics of theophyllineT A Branigan, R A Robbins, W J Cady, et al.
Bulletin Du Cancer|January 1, 1991
[Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer]C Louvet, A de Gramont, B Demuynck, et al.
JAMA|March 16, 1990
An assessment of diltiazem and hydrochlorothiazide in hypertension. Application of factorial trial design to a multicenter clinical trial of combination therapyJ F Burris, M R Weir, S Oparil, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 25, 2022
Development of the functional assessment of migraine scale using a patient guided approachErin M Buchanan, Heather R Manley, James S Sly, et al.
Journal of Human Hypertension|April 1, 1992
A dose escalation trial comparing the combination of diltiazem SR and hydrochlorothiazide with the monotherapies in patients with essential hypertensionM R Weir, M A Weber, H A Punzi, et al.
European Journal of Integrative Medicine|September 22, 2015
The Role of Salivary Neuropeptides in Pediatrics: Potential Biomarkers for Integrated TherapiesLynn A Gershan, Paul L Durham, Jaci Skidmore, et al.
American Heart Journal|February 1, 1980
Mexiletine in the treatment of refractory ventricular arrhythmias: a report of five casesW J Cady, C S Wilson, W A Chambers, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Acute effects of increasing doses of urapidil in patients with hypertensionV L Culbertson, P J Bryant, W J Cady, et al.
Pageof 9